PBC Biomed Appoints Mark McMahan as Chief Commercial Officer

New Hire /

Irish medical device company PBC Biomed today announced the appointment of Mark McMahan as Chief Commercial Officer, effective October 2025. McMahan, formerly Vice President of Global & US Trauma & Extremities Marketing at Smith & Nephew, brings extensive international expertise in medical device commercialization and strategy. In his new role, McMahan will oversee global commercialization […]

PBC Biomed Appoints Mark McMahan as Chief Commercial Officer Read More »

PBC Biomed Poster Presentation at ESB 2025

Biomaterials, Bone Adhesive, Bone Healing, Development, Events, Research /

Congratulations to Senior R&D Engineer Antzela Tzagiollari on her poster presentation at the ESB 2025 event yesterday, highlighting her team’s research on OsStic® as a promising next-generation biomaterial. Their findings show that OsStic® uniquely combines bone adhesion, mechanical strength, and prolonged antibiotic delivery. While incorporating vancomycin reduced its strength, OsStic® still demonstrated clinically acceptable performance.

PBC Biomed Poster Presentation at ESB 2025 Read More »

First Call for Papers – Bioadhesive Symposium at ESB 2026

Biomaterials, Bone Adhesive, Bone Healing, Events, Research /

We are excited to announce our first call for papers for the PBC Biomed #Bioadhesive Symposium, which will be held as part of next year’s ESB Meeting in Antwerp, Belgium. The symposium will be chaired by Prof. Nicholas Dunne (DCU, Ireland) and feature keynote lectures from Prof. Håkan Engqvist (Uppsala University, Sweden), Dr. Marc Bohner

First Call for Papers – Bioadhesive Symposium at ESB 2026 Read More »

PBC Biomed expertise on OCP Manufacturing & Research – Learn more at ESB 2025

Biomaterials, Conferences, Contract Manufacturing, Development, Research /

PBC Biomed is internationally recognised for its expertise in the manufacturing and research of Octa-calcium Phosphate (OCP), as well as in the advancement of innovative biomedical technologies. Our team will be on booth #20 during the #ESB meeting next week to provide insights into our ongoing research initiatives, development programmes, and future technological advancements. We

PBC Biomed expertise on OCP Manufacturing & Research – Learn more at ESB 2025 Read More »

PBC Biomed are attending ESB 2025 in Turin

Biomaterials, Bone Adhesive, Conferences, Research, Upcoming Events /

PBC Biomed is excited to be attending this year’s European Society for Biomaterials (ESB) meeting in Turin! Our Senior R&D Engineer, Antzela Tzagiollari, will be presenting her poster titled: “Evaluation of OsStic® as a Dual-Function Bone Adhesive for Sustained Antibiotic Delivery and Mechanical Integrity in Orthopaedic Surgery.” We’re also pleased to announce that we are

PBC Biomed are attending ESB 2025 in Turin Read More »

PBC Biomed Inc team meet Frank Groome, Consul General of Ireland in Atlanta

Memphis Office, Regenerative Medicine, Relationship-building, US Office /

This week, our leadership team had the pleasure of meeting with Frank Groome, the Consul General of Ireland in Atlanta, for an insightful discussion centred on collaboration and deepening relationships. Our team were inspired to hear about the Consulate’s continued commitment to fostering international partnerships, innovation, and mutual growth. Pictured below from L-R is Patrick

PBC Biomed Inc team meet Frank Groome, Consul General of Ireland in Atlanta Read More »

PBC BioVet Team showcase OssiVet® in the US!

Biomaterials, Biovet, Bone Adhesive, Bone Healing /

We’re hitting the road!The PBC BioVet team on are tour across the state of Texas in the US to showcase OssiVet®, our advanced veterinary bone adhesive making waves in animal orthopedic surgery.From Dallas to Houston and Austin, in-person demos, clinical discussions, and hands-on presentations on how OssiVet® can:– Support fracture management– Improve implant fixation Remodel into new bone

PBC BioVet Team showcase OssiVet® in the US! Read More »